Nodular Lymphocyte-Predominant Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch Nodular Lymphocyte-Predominant Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Immune Responses to COVID-19 Vaccination in Lymphoma Patients (NCT04858568) | University Hospital Southampton NHS Foundation Trust | 2021-03-11 |
| Rituximab in Treating Patients With Hodgkin's Lymphoma (NCT00003820) | Ranjana Advani | 1999-01-01 |
Track Nodular Lymphocyte-Predominant Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.